Targeting Residual Inflammation in Cardiovascular Disease: Beyond LDL Cholesterol Toward Precision Cardiometabolic Prevention
Current evidence supports a transition toward comprehensive cardiometabolic prevention integrating lipid management, lifestyle modification, metabolic optimization, and targeted anti-inflammatory therapy and future precision medicine strategies incorporating inflammatory biomarkers and individualized risk assessment ma...